IMMURON (IMRN) vs NKGen Biotech, Inc. (NKGN)
IMMURON and NKGen Biotech, Inc. are both Biotechnology companies. IMMURON and NKGen Biotech, Inc. are of similar size ($9.6M and $8.8M). NKGen Biotech, Inc. has the higher net margin (0.00% vs −262.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 9 metrics below, NKGen Biotech, Inc. leads on 5 and IMMURON on 4.
Valuation
Profitability
| Metric | IMRN | NKGN | Biotechnology median |
|---|---|---|---|
| Gross margin | 71.28% | — | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | (262.71%) | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 0.00% | 44.70% | (57.72%) |
| Return on assets | 0.00% | (146.49%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack